BiVictriX Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
BiVictriX Therapeutics has a total shareholder equity of £3.5M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £4.3M and £758.0K respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
Interest coverage ratio | n/a |
Cash | UK£3.28m |
Equity | UK£3.54m |
Total liabilities | UK£758.00k |
Total assets | UK£4.30m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BVX's short term assets (£3.8M) exceed its short term liabilities (£624.0K).
Long Term Liabilities: BVX's short term assets (£3.8M) exceed its long term liabilities (£134.0K).
Debt to Equity History and Analysis
Debt Level: BVX is debt free.
Reducing Debt: BVX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BVX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: BVX has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 35% each year.